Pseudocarcinomatous hyperplasia hiding lymphomatoid papulosis: A "low-power view" pitfall

Salvatore Bellafiore, Laura Grenzi, Vito Simonetti, Simonetta Piana

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pseudocarcinomatous hyperplasia (PCH) is a reactive proliferation of the epidermis that can be associated with many inflammatory and neoplastic conditions. Histologically, it is characterized by irregular strands of epidermis, usually at the level of the follicular infundibulum, projecting downward into the dermis. The differentiation between a well-differentiated squamous cell carcinoma and PCH can be particularly challenging when the biopsy is superficial and the causing lesion is dermal-based. Lymphomatoid papulosis (LyP) is an uncommon, self-healing, recurrent, cutaneous T-cell lymphoma, included among the primary cutaneous CD30-positive T-cell lymphoproliferative disorders. LyP is characterized by a chronic course of years to decades that does not compromise survival, even if patients with LyP are at risk for second cutaneous or nodal lymphoid malignancies. LyP and other lymphomas are major neoplastic causes of PCH and can be misdiagnosed or completely overlooked if the PCH is particularly exuberant. We describe the case of an otherwise healthy 55-year-old man who presented with a 3-month history of erythematous papules on upper and lower limbs. A diagnosis of LyP associated with PCH was made after 3 skin biopsies. The propensity of the CD30+ cutaneous lymphoproliferative disorders to an incognito growth pattern is well recognized, and a low-magnification scanning of the histological slides can be an inappropriate approach.

Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalInternational Journal of Surgical Pathology
Volume24
Issue number3
DOIs
Publication statusPublished - 2015

Fingerprint

Lymphomatoid Papulosis
Hyperplasia
Skin
Lymphoproliferative Disorders
Epidermis
Biopsy
Cutaneous T-Cell Lymphoma
Pituitary Gland
Dermis
Diagnostic Errors
Squamous Cell Carcinoma
Lower Extremity
Lymphoma
T-Lymphocytes
Survival
Growth
Neoplasms

Keywords

  • CD30 positive
  • lymphomatoid papulosis
  • pitfall
  • pseudocarcinomatous hyperplasia

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Pseudocarcinomatous hyperplasia hiding lymphomatoid papulosis : A "low-power view" pitfall. / Bellafiore, Salvatore; Grenzi, Laura; Simonetti, Vito; Piana, Simonetta.

In: International Journal of Surgical Pathology, Vol. 24, No. 3, 2015, p. 232-236.

Research output: Contribution to journalArticle

Bellafiore, Salvatore ; Grenzi, Laura ; Simonetti, Vito ; Piana, Simonetta. / Pseudocarcinomatous hyperplasia hiding lymphomatoid papulosis : A "low-power view" pitfall. In: International Journal of Surgical Pathology. 2015 ; Vol. 24, No. 3. pp. 232-236.
@article{0c28b2eb84014b9383aa311bfc0b3d89,
title = "Pseudocarcinomatous hyperplasia hiding lymphomatoid papulosis: A {"}low-power view{"} pitfall",
abstract = "Pseudocarcinomatous hyperplasia (PCH) is a reactive proliferation of the epidermis that can be associated with many inflammatory and neoplastic conditions. Histologically, it is characterized by irregular strands of epidermis, usually at the level of the follicular infundibulum, projecting downward into the dermis. The differentiation between a well-differentiated squamous cell carcinoma and PCH can be particularly challenging when the biopsy is superficial and the causing lesion is dermal-based. Lymphomatoid papulosis (LyP) is an uncommon, self-healing, recurrent, cutaneous T-cell lymphoma, included among the primary cutaneous CD30-positive T-cell lymphoproliferative disorders. LyP is characterized by a chronic course of years to decades that does not compromise survival, even if patients with LyP are at risk for second cutaneous or nodal lymphoid malignancies. LyP and other lymphomas are major neoplastic causes of PCH and can be misdiagnosed or completely overlooked if the PCH is particularly exuberant. We describe the case of an otherwise healthy 55-year-old man who presented with a 3-month history of erythematous papules on upper and lower limbs. A diagnosis of LyP associated with PCH was made after 3 skin biopsies. The propensity of the CD30+ cutaneous lymphoproliferative disorders to an incognito growth pattern is well recognized, and a low-magnification scanning of the histological slides can be an inappropriate approach.",
keywords = "CD30 positive, lymphomatoid papulosis, pitfall, pseudocarcinomatous hyperplasia",
author = "Salvatore Bellafiore and Laura Grenzi and Vito Simonetti and Simonetta Piana",
year = "2015",
doi = "10.1177/1066896915623364",
language = "English",
volume = "24",
pages = "232--236",
journal = "International Journal of Surgical Pathology",
issn = "1066-8969",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Pseudocarcinomatous hyperplasia hiding lymphomatoid papulosis

T2 - A "low-power view" pitfall

AU - Bellafiore, Salvatore

AU - Grenzi, Laura

AU - Simonetti, Vito

AU - Piana, Simonetta

PY - 2015

Y1 - 2015

N2 - Pseudocarcinomatous hyperplasia (PCH) is a reactive proliferation of the epidermis that can be associated with many inflammatory and neoplastic conditions. Histologically, it is characterized by irregular strands of epidermis, usually at the level of the follicular infundibulum, projecting downward into the dermis. The differentiation between a well-differentiated squamous cell carcinoma and PCH can be particularly challenging when the biopsy is superficial and the causing lesion is dermal-based. Lymphomatoid papulosis (LyP) is an uncommon, self-healing, recurrent, cutaneous T-cell lymphoma, included among the primary cutaneous CD30-positive T-cell lymphoproliferative disorders. LyP is characterized by a chronic course of years to decades that does not compromise survival, even if patients with LyP are at risk for second cutaneous or nodal lymphoid malignancies. LyP and other lymphomas are major neoplastic causes of PCH and can be misdiagnosed or completely overlooked if the PCH is particularly exuberant. We describe the case of an otherwise healthy 55-year-old man who presented with a 3-month history of erythematous papules on upper and lower limbs. A diagnosis of LyP associated with PCH was made after 3 skin biopsies. The propensity of the CD30+ cutaneous lymphoproliferative disorders to an incognito growth pattern is well recognized, and a low-magnification scanning of the histological slides can be an inappropriate approach.

AB - Pseudocarcinomatous hyperplasia (PCH) is a reactive proliferation of the epidermis that can be associated with many inflammatory and neoplastic conditions. Histologically, it is characterized by irregular strands of epidermis, usually at the level of the follicular infundibulum, projecting downward into the dermis. The differentiation between a well-differentiated squamous cell carcinoma and PCH can be particularly challenging when the biopsy is superficial and the causing lesion is dermal-based. Lymphomatoid papulosis (LyP) is an uncommon, self-healing, recurrent, cutaneous T-cell lymphoma, included among the primary cutaneous CD30-positive T-cell lymphoproliferative disorders. LyP is characterized by a chronic course of years to decades that does not compromise survival, even if patients with LyP are at risk for second cutaneous or nodal lymphoid malignancies. LyP and other lymphomas are major neoplastic causes of PCH and can be misdiagnosed or completely overlooked if the PCH is particularly exuberant. We describe the case of an otherwise healthy 55-year-old man who presented with a 3-month history of erythematous papules on upper and lower limbs. A diagnosis of LyP associated with PCH was made after 3 skin biopsies. The propensity of the CD30+ cutaneous lymphoproliferative disorders to an incognito growth pattern is well recognized, and a low-magnification scanning of the histological slides can be an inappropriate approach.

KW - CD30 positive

KW - lymphomatoid papulosis

KW - pitfall

KW - pseudocarcinomatous hyperplasia

UR - http://www.scopus.com/inward/record.url?scp=84964648763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964648763&partnerID=8YFLogxK

U2 - 10.1177/1066896915623364

DO - 10.1177/1066896915623364

M3 - Article

AN - SCOPUS:84964648763

VL - 24

SP - 232

EP - 236

JO - International Journal of Surgical Pathology

JF - International Journal of Surgical Pathology

SN - 1066-8969

IS - 3

ER -